Omeros announces additional data from Phase 2 trial of OMS103HP for arthroscopic meniscectomy surgery

Download PDF Copy

May 3 2010

Omeros Corporation (Nasdaq: OMER) today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits. OMS103HP is an investigational drug product that is added to arthroscopic irrigation solution and is designed to improve postoperative joint function and motion and reduce postoperative pain. Omeros plans to present these additional data tomorrow in its webcast presentation at the Deutsche Bank Health Care Conference at 2:50 p.m. EDT and, for those not attending, has provided the clinical trial results below.

SOURCE Omeros Corporation

Posted in: Drug Trial News | Medical Procedure News | Medical Condition News

Tags: Antibody, Arthroscopy, Autism, Cartilage, Clinical Trial, Genetics, Health Care, Meniscectomy, Nervous System, Osteoarthritis, Pain, Surgery

Comments (0)

Download PDF Copy

Suggested Reading

Genetic variant identified as potential predictor for severe ulcerative colitis

Genetic variant identified as potential predictor for severe ulcerative colitis

Weight loss drug semaglutide may offer relief for knee arthritis pain

Weight loss drug semaglutide may offer relief for knee arthritis pain

Early bilateral oophorectomy linked to increased Alzheimer's disease risk

Early bilateral oophorectomy linked to increased Alzheimer's disease risk

Memories of obesity can linger in fat cells long after weight loss

Memories of obesity can linger in fat cells long after weight loss

AI-powered MRI predicts outcomes in prostate cancer

AI-powered MRI predicts outcomes in prostate cancer

Stem-cell implants restore vision in patients with corneal stem cell deficiency

Stem-cell implants restore vision in patients with corneal stem cell deficiency

Are back problems influenced by your gut?

Are back problems influenced by your gut?

Low-carb diet may improve beta-cell function in type 2 diabetes patients

Low-carb diet may improve beta-cell function in type 2 diabetes patients

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Cesarean deliveries during labor linked to risks in future pregnancies